Literature DB >> 22530772

IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology.

Muhammad I Arshad1, Claire Piquet-Pellorce, Michel Samson.   

Abstract

'Alarmins' are a group of proteins or molecules that are released from cells during cellular demise to alert the host immune system. Two of them, Interleukin-33 (IL-33) and high-mobility group box-1 (HMGB1), share many similarities of cellular localization, functions and involvement in various inflammatory pathologies including hepatitis. The expressions of IL-33 and HMGB1, and their receptors ST2 and receptor for advanced glycation end products (RAGE), are substantially up-regulated during acute and chronic hepatitis. Recent data evidence a possible protective role of IL-33/ST2 axis during liver injury. A contrast in expression of IL-33 and HMGB1 alarmins were associated with type of hepatocellular death mediated by immune cells or hepato-toxic agents. The massive release of active form of IL-33 from hepatocytes may affect the recruitment and activation of its ST2-positive target immune cells in the liver to confer its alarmin functions. This review highlights the emerging roles of alarmin proteins in various liver pathologies, by focusing on classical HMGB1 and a newly discovered alarmin, the IL-33.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22530772     DOI: 10.1111/j.1478-3231.2012.02802.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  29 in total

Review 1.  Liver macrophages in tissue homeostasis and disease.

Authors:  Oliver Krenkel; Frank Tacke
Journal:  Nat Rev Immunol       Date:  2017-03-20       Impact factor: 53.106

2.  Mouse Hepatitis Virus Infection Induces a Toll-Like Receptor 2-Dependent Activation of Inflammatory Functions in Liver Sinusoidal Endothelial Cells during Acute Hepatitis.

Authors:  Christian Bleau; Aveline Filliol; Michel Samson; Lucie Lamontagne
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

3.  IL-33 enhances macrophage release of IL-1β and promotes pain and inflammation in gouty arthritis.

Authors:  Victor Fattori; Larissa Staurengo-Ferrari; Tiago H Zaninelli; Rubia Casagrande; Rene D Oliveira; Paulo Louzada-Junior; Thiago M Cunha; Jose C Alves-Filho; Mauro M Teixeira; Fernando Q Cunha; Flavio A Amaral; Waldiceu A Verri
Journal:  Inflamm Res       Date:  2020-09-04       Impact factor: 4.575

4.  The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver.

Authors:  Muhammad Imran Arshad; Claire Piquet-Pellorce; Aveline Filliol; Annie L'Helgoualc'h; Catherine Lucas-Clerc; Sandrine Jouan-Lanhouet; Marie-Thérèse Dimanche-Boitrel; Michel Samson
Journal:  J Mol Med (Berl)       Date:  2015-03-08       Impact factor: 4.599

5.  Interleukin-33 and receptor ST2 as indicators in patients with asthma: a meta-analysis.

Authors:  Rui Li; Gang Yang; Ruiqi Yang; Xiaoxing Peng; Jing Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 6.  Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.

Authors:  Octavie Rostan; Muhammad Imran Arshad; Claire Piquet-Pellorce; Florence Robert-Gangneux; Jean-Pierre Gangneux; Michel Samson
Journal:  Infect Immun       Date:  2015-02-23       Impact factor: 3.441

7.  Released Tryptophanyl-tRNA Synthetase Stimulates Innate Immune Responses against Viral Infection.

Authors:  Hyun-Cheol Lee; Eun-Seo Lee; Md Bashir Uddin; Tae-Hwan Kim; Jae-Hoon Kim; Kiramage Chathuranga; W A Gayan Chathuranga; Mirim Jin; Sunghoon Kim; Chul-Joong Kim; Jong-Soo Lee
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

Review 8.  Inflammasome activation and function in liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

9.  High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma.

Authors:  Dominik Bergis; Valentin Kassis; Annika Ranglack; Verena Koeberle; Albrecht Piiper; Bernd Kronenberger; Stefan Zeuzem; Oliver Waidmann; Heinfried H Radeke
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

10.  NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice.

Authors:  Annie-Carole Tosello-Trampont; Peter Krueger; Sowmya Narayanan; Susan G Landes; Norbert Leitinger; Young S Hahn
Journal:  Hepatology       Date:  2016-01-21       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.